According to Renub Research report titled “Medical Adhesives Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the Medical Adhesives Market to reach USD 15.30 Billion by 2027. In the assembly of medical devices, medical adhesives comprise an integral part of healthcare delivery and are used by almost every medical specialty in all care settings. Medical adhesives are biocompatible, and their features of not irritating, sensitizing, or cytotoxic have expanded their use in medical equipment. Medical adhesives are majorly utilized in the medical industry to close up a patch or dress the skin wounds, fix medical devices such as tape, etc. It is utilized for bone and enamel reconstruction during surgeries. Various products are involved in medical adhesives, such as dressing, electrodes, patches tapes, and ostomy supplies.

Worldwide Medical Adhesives Market Size was US$ 9.70 Billion in 2021

Nonetheless, the population in developed countries such as the U.S., Germany, and Japan is aging rapidly. As per the United States Census Board, people above 65 years would account for 20% of the total population by 2030. According to the (UNU) United Nations University, one million people reach 60 years of age every month globally. The increasing geriatric population is the factor that increases medical adhesives demand, which in turn anticipated driving the development of the global market in the next few years. Further, the demand for silicone-based medical adhesives is caused by their ability to adhesion silicon and other difficult-to adhere substrates. In addition, silicone is characterized by extreme weather resistance and has more extended durability than acrylics.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=medical-adhesives-market-p.php

Dental application is the Fastest-growing Segment of Medical Adhesives Industry

In terms of application, the global medical adhesives market is categorized into medical device & equipment, internal, external, dental, and others. Dental adhesives deliver retention to composite fillings or composite cement. These adhesives find use in pit & fissure sealants and dental repair applications. Products in dental applications include Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives.

Apart from this, medical devices & equipment are utilized for hearing-aid molding, polycarbonate component assembly (e.g., heat exchangers, blood oxygenators, and surgical pumps) anesthesia-mask bonding, needle assembly, bonding of other medical devices. The product's substrate versatility, thermal solid & chemical resistance, low shrinkage, high gap filling, high peel, and rapid cure are the significant factors driving their growth in medical devices & equipment.

North America to Lead Global Medical Adhesives Industry

In North America, increased patient awareness levels regarding wound infections and diseases and the rapidly growing senior population in this region, especially in the U.S, are the significant factors contributing to market growth. The evolution of the market player’s focus towards developed wound dressings analogized to the traditional staple and suture methods is the major trend witnessed in this region.

Notwithstanding, the Asia Pacific is the fastest-growing medical adhesive market. The Asia-Pacific medical adhesive market is predicted to expand due to the growing population, driving up the need for better medical facilities and preferring adhesive medical demand. The consistent increase in government spending on the healthcare sector and the updating of healthcare infrastructure are market expansions in this area.

COVID-19 Impact on Medical Adhesive

The pandemic had ramifications for ways of working of various surgical procedures. There are stringent guidelines specific to each specialty that must be implemented and followed for surgeons to continue providing adequate care and safety to their patients during the COVID-19 pandemic. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries, impacting the procurement of the medical adhesives market.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/medical-adhesives-market-p.php

Key Market Players

Numerous big and small players characterize the global medical adhesives market. The major market players include Avery Dennison Corporation, Ashland Global Holdings Inc., H.B. Fuller Company, Henkel AG & Co. KGaA, The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Dupoint De Nemours, Inc and Wacker Chemie AG.

Market Summary:

Product - We have covered Market breakup by 2 viewpoints by product (Synthetic & Semi-Synthetic Adhesives (Acrylic, Polyurethane, Epoxy, Silicone, and Others) and Natural or Biological Adhesive (Fibrin, Collagen, Albumin, and Others)

Application - Our Report covers by Application in the 5 viewpoints (Dental (Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives), Internal (Bone, Cranial, Pulmonary and Abdominal), External (Tissue Bonding Agents and Prosthesis Bonding Agents), Medical Device & Equipment and Others)

Technology – Global Medical Adhesives Market have been covered by technology from 5 viewpoints (Water based, Solvent based, Hot melt, Reactive & Others)

Region - This Report covers Global Medical Adhesives Market breakup by 4 Region (North America, Europe, Asia - Pacific, Central & South America, and Middle East)

All the key players have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) H.B. Fuller Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Ashland Global Holdings Inc., The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Wacker Chemie AG, and Dupoint De Nemours, Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” United States Cardiovascular Devices Market Size was US$ 25.34 Billion in 2020. Cardiovascular diseases, or CVDs in the United States, have continued to be considered among the top pain counts of the medical application. Additionally, with conditions like stroke or IHD (ischemic heart disease) adding heavily to death and disability, cardiovascular devices and their consequence in heart-related therapies are quickly being brought into the spotlight in the country. Further, fatalities caused due to CVDs have been rising steadily over the years.

According to a study by Communicable Disease Center (CDC), one of the major operating components of the Department of Health and Human Services and recognized as the nation's premier health promotion, prevention, and preparedness agency, claims heart attack to be the principal cause of death for men, women, and people of most significant racial and ethnic groups in the United States. Consequently, these alarming situations are a testament that the U.S. need to implement cost-effective health devices and therapies designed to mitigate the risk of CVDs. Wherein development and deployment of effective and advanced medical devices is a crucial part of these efforts.

Move Towards Minimally Invasive Treatment Solutions:

In the United States, minimally invasive surgical procedures, especially in the cardiovascular discipline, have continued to gain favour over the years due to myriad benefits like minimal damage to the body, less pain, and lower risk of complications correlated to open operations. Drawn initially to match in the mid-90s, the MIS procedures accompanied the realization of the preeminent coronary artery and heart valve bypass employing the least access routes.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-cardiovascular-devices-market-p.php

Further, the preference for minimally invasive procedures is driven by advancements in cardiovascular medical device technologies. These developments are instrumental in positioning minor invasive procedures as the operating method of choice. They rely heavily on catheters and other specialized medical equipment to be injected into the body through tiny cuts for therapeutic intrusions and demonstrative measures.

For instance, innovative discoveries like smart balloon catheter systems are decked with electronics, sensors and mechanisms. The intelligent technology is consistently redesigned to deliver ablation therapy, blood flow data, haematological data and electrical instigation through a single device. In September 2020, a unit of researchers led by technicians at Northwestern University and George Washington University outlined a balloon catheter system. It was implemented with flexible and stretchable patterns of electrode actuators and sensors and pressure and temperature sensors. These are frequently used in minimally invasive ablations or surgeries in operating conditions such as heart arrhythmias.

The Emergence of Sophisticated and Innovative Cardiac Ablation Devices:

As the burden of cardiovascular ailments in the United States medical realm remains to grow over the years, the adoption of superior treatment technologies will behold a significant upsurge, creating productive growth roads for the cardiovascular device industry in the years ahead. By Device Type, Renub Research holds meaningful existence of devices like Peripheral Vascular Device, Prosthetic Heart Valves, Cardiac Rhythm Management Device, Cardiac Assist Devices, Cardiovascular Surgery Devices, External Defibrillators, Clot Management Devices and Cardiovascular Prosthetic Devices in the United States Cardiovascular Devices Market. Wherein, the rising prevalence of atrial fibrillation is an essential contributor to the popularity of these devices. Remarkably, in cardiac ablation device technologies, the products are inscribing an ever-increasing demand for minimally invasive ablation procedures and discovery.

For example, in June 2020, Boston Scientific launched the DIRECTSENSE technology in the United States as a tool intended to monitor the impact of radiofrequency energy delivery through cardiac ablation processes. Similarly, in 2020, Abbott restarted its LIFE-BTK clinical trial to assess the safety and effectiveness of its new Esprit BTK Everolimus-Eluting Resorbable Scaffold System. This is the advancing investigational device exemption (IDE) trial in the United States to assess an utterly bio-resorbable stent to heal blocked arteries underneath the knees, or critical limb ischemia (CLI), in people undergoing the first stages of peripheral artery disease (PAD).United States Cardiovascular Devices Market will grow with a CAGR of 6.7% during 2021-2027.

The evident reinforcement of the cardiovascular devices market is hinged through key end-users like Hospitals, Cardiac Diagnostic Centres and Ambulatory Surgical centres factoring the risk of CVDs and related health problems are recognized today on a grander scale the region. Further, the market growth can be attributed to a thriving healthcare recognition through visibility on the internet, private hospital heart plans and public outreach plans from government bureaus like the CDC. In addition, consumers are alert to the symptoms of developing a heart disorder, the need for early diagnosis and available treatment options. The fast-expanding geriatric population base will only fuel the potential of the medical devices sector.

Consequently, heart disease is the preeminent instigator of death in the United States, affecting a large population in the United States each year. Precisely, more than millions of Americans are living with some form of cardiovascular disease or stroke. In addition to the rising pervasiveness of CVD, there is a surge in comorbidities, which involves chronic pain, arrhythmias, diabetes and depression, and are more widespread in the elderly medicare groups. Given the expected uptick in CVD, comorbidities, and blended analysis and medication, the financial strain of CVD also is expected to expand, with the determined direct cost of CVD in the US.

The consequence of COVID-19 Pandemic against Cardiovascular Device Industry:

Amidst the first half of 2020, the COVID-19 pandemic has negatively impacted the cardiovascular devices industry. The Coronavirus has modified the production of cardiovascular devices businesses as there was a postponement of elective procedures. Only those cardiovascular projects were analyzed, which were critical; others have been suspended and limited since the commencement of the global pandemic.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-cardiovascular-devices-market-p.php

Another factor negatively influencing the industry was the deterioration in the analysis of cardiovascular diseases as the healthcare devices were being redirected to Coronavirus patients. However, the monthly revenues of cardiovascular devices companies rebounded in H2 2020 and are back on track.

Market Summary:

Device Type - We have covered the market comprising of Cardiac Rhythm Management Device, Peripheral Vascular Device, Prosthetic Heart Valves, Cardiac Assist Devices, Cardiovascular Surgery Devices, External Defibrillators, Clot Management Devices, Cardiovascular Prosthetic Device, Others.

End–Users - We have studied the market Hospitals, Cardiac Diagnostic Centres, and Ambulatory Surgical Centre existing as end users in the United States Cardiovascular Devices

Company - We have studied the company by Company Overview, Recent Development and Financial Insights of following companies Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC, and GE Healthcare.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “Point of Care Diagnostic Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Point of Care Diagnostics Market is expected to be USD 44 Billion by 2027. Point-of-care testing is essential for rapidly detecting analyses near the patient, facilitating better monitoring, disease diagnosis, and management. POC tests are executed outside central laboratories and produce quick results. POC has been a vital goal in vitro diagnostics, and new consequences have made achieving it possible. Point of care diagnostics will be part of a paradigm shift from corrective medicine to predictive, personalized, and preemptive treatment.

Around the world, the demand for POC diagnostics is rapidly growing because of the prevalence of acute and chronic diseases. As per World Health Organization (WHO), in 2019, about 10 million people were impacted by tuberculosis globally, and 1.4 million people died from tuberculosis. Moreover, according to the United Nations Program on HIV/AIDS (UNAIDS), worldwide; around 37.7 million people were living with HIV in 2020. The demand for diagnosis products among patients is probable to boost the POC diagnostics market growth.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=point-of-care-diagnostic-market-p.php

Factors Driving Point of Care Testing Market

Furthermore, Point-of-care is gaining wide acceptance by different patients worldwide, as samples are collected from the patient’s location for tests. The results can be achieved significantly less due to micro fluids, nano diagnostics, and chips. Factors such as the increasing regulatory support for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices drive market growth. Point-of-care testing diagnostics have numerous advantages, which allow patient diagnoses at many places, such as in the ambulance, physician’s office, home, field, or hospital. The upshots of care are timely and quickly remedy the patient.

How COVID-19 Benefited the Global Point Of Care Diagnostics Industry:

The COVID-19 pandemic has dramatically affected the point of care diagnostics market. The outbreak of COVID-19 has expedited the global demand for diagnostic kits to detect the disease rapidly. Regardless, owing to the increasing usage of POC tests that can rapidly diagnose COVID-19. With the enlargement in demand for speedy diagnostic results, the adoption of point-of-care testing is booming. The rapidly extending number of COVID-19 cases and the growing pressure on governments to improve patient management have raised the demand for rapid antigen testing kits that can be virtually used in point-of-care settings.

Coagulation Monitoring Testing is the Major Revenue Share

Based on Diagnostics type, Point-of-care testing (POCT) diagnostics market segmented into Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hematology Testing, Cardiometabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers. The rising number of patients suffering from bleeding disorders such as Von Willebrand, hemophilia, and venous thromboembolism generate considerable demand for Coagulation Monitoring testing.

Worldwide the rising prevalence of diabetes demands for Blood glucose testing point-of-care diagnostics due to the triumph of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose levels is vital for diabetic patients, encouraging POC adoption among diabetic patients. Nevertheless, technology such as Lateral Flow technology uses across healthcare. There is an enormous demand for this segment owing to the advantage offered by lateral flow assay assays in POC testing by replacing lengthy, conventional laboratory procedures.

Regional Analysis: United States Controls the Point of Care Diagnostics Industry

Currently, the United States has highest market for point-of-care-diagnostics globally. This can be attributed to the country's growing geriatric population base and the aspects such as the increasing plurality of disorders and the flawless government regulations and initiatives undertaken for the evolution of healthcare infrastructure. Besides, the Asia-Pacific industry is to witness considerable enlargement due to the higher adoption of POC diagnostics kits in India. China is another significant factor supporting the growth in the Asia Pacific region.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/point-of-care-diagnostic-market-p.php

Competitive Landscape:

The point-of-care diagnostics market is relatively competitive and consists of several major players such as Sysmex, Abbott Laboratories (US, Becton Dickinson and Company (US), Danaher Corporation (US), Quidel Diagnostics (US)

Market Summary:

• Diagnostics Types – Renub Research Report covered by Diagnostics Types in the 8 viewpoints (Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hermatology Testing, Cardio metabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers)
• Technology - Our Report covers by Technology in the 5 viewpoints (Biosensor, Lateral Flow, Agglutination, Flow Through, Solid phase)
• End User - We have covered Point of Care Diagnostics Market by  End User in the 4 viewpoints (Hospital, Clinics, Diagnostic centers, others)
• Country - This Report covers Point of Care Diagnostic Market breakup by 12 country (United States, China, Japan, United Kingdom, Germany, Spain, Italy, Argentina, India, Brazil, Canada, Mexico)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Sysmex, Abbott Laboratories (US, Becton Dickinson and Company (US), Danaher Corporation (US),Quidel Diagnostics (US)

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch